164 related articles for article (PubMed ID: 16889500)
1. Thyroid stimulation-blocking antibody and Graves' ophthalmopathy.
Kubota S; Fukata S; Amino N; Miyauchi A
Thyroid; 2006 Jul; 16(7):708. PubMed ID: 16889500
[No Abstract] [Full Text] [Related]
2. Eye signs of graves' disease and blocking-type thyrotropin receptor autoantibodies.
Rees Smith B; Nordmeyer P; Sanders J; Furmaniak J
Thyroid; 2006 Jan; 16(1):97-8. PubMed ID: 16487022
[No Abstract] [Full Text] [Related]
3. Simple radioimmunological assay of anti-alpha-galactosyl antibody (anti-Gal): application to autoimmune thyroid diseases and thyroid-associated ophthalmopathy.
Winand RJ; Winand-Devigne J; Cox C; Caulier C; Meurisse M
J Endocrinol Invest; 1995 Nov; 18(10):749-53. PubMed ID: 8787950
[TBL] [Abstract][Full Text] [Related]
4. The pathogenetic connection between Graves' disease and chronic lymphocytic thyroiditis. (The role and incidence of thyroid stimulating antibodies).
Leövey A; Bakó G; Sztojka I; Bordán L; Szabó T; Kálmán K; Balázs C
Acta Med Acad Sci Hung; 1982; 39(1-2):1-6. PubMed ID: 6129766
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
7. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease.
Ross PV; Koenig RJ; Arscott P; Ludgate M; Waier M; Nelson CC; Kaplan MM; Baker JR
J Clin Endocrinol Metab; 1993 Aug; 77(2):433-8. PubMed ID: 8345048
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
Kiljanski JI; Peele K; Stachura I; Pickeral J; Stolarski C; Kennerdell JS; Wall JR
J Endocrinol Invest; 1997 Nov; 20(10):585-91. PubMed ID: 9438915
[TBL] [Abstract][Full Text] [Related]
9. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.
Wiersinga WM; Smit T; van der Gaag R; Koornneef L
J Endocrinol Invest; 1988 Sep; 11(8):615-9. PubMed ID: 2907524
[TBL] [Abstract][Full Text] [Related]
10. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
McLachlan SM; Bahn R; Rapoport B
Autoimmunity; 1992; 14(2):143-8. PubMed ID: 1363894
[TBL] [Abstract][Full Text] [Related]
11. Graves' ophthalmopathy and tobacco smoking.
Tallstedt L; Lundell G; Taube A
Acta Endocrinol (Copenh); 1993 Aug; 129(2):147-50. PubMed ID: 8103953
[TBL] [Abstract][Full Text] [Related]
12. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
[TBL] [Abstract][Full Text] [Related]
13. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
Li J; Gao H; Jin SX
Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
[TBL] [Abstract][Full Text] [Related]
14. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
15. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.
Nishikawa M; Yoshimura M; Toyoda N; Masaki H; Yonemoto T; Gondou A; Kato T; Kurokawa H; Furumura T; Inada M
Acta Endocrinol (Copenh); 1993 Sep; 129(3):213-9. PubMed ID: 8105634
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
[No Abstract] [Full Text] [Related]
17. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
Ohkura T; Taniguchi S; Yamada K; Nishio N; Okamura T; Yoshida A; Kamijou K; Fukata S; Kuma K; Inoue Y; Hisatome I; Senju S; Nishimura Y; Shigemasa C
Biochem Biophys Res Commun; 2004 Aug; 321(2):432-40. PubMed ID: 15358194
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
[TBL] [Abstract][Full Text] [Related]
19. Immunologic aspects of Graves' and Hashimoto's diseases.
Kidd A; Okita N; Row VV; Volpé R
Metabolism; 1980 Jan; 29(1):80-99. PubMed ID: 6986013
[No Abstract] [Full Text] [Related]
20. The common incidence of Basedow's-Graves' disease and chronic lymphocytic thyroiditis.
Leövey A; Bakó G; Sztojka I; Szabó J; Kálmán K; Szabó T
Radiobiol Radiother (Berl); 1984; 25(5):769-74. PubMed ID: 6150513
[No Abstract] [Full Text] [Related]
[Next] [New Search]
